cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

cbdMD, Inc. has announced a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, a well-established name in the nutritional supplements sector. The deal, which is valued at an undisclosed amount, is expected to enhance cbdMD's revenue to approximately $30 million. This acquisition, revealed on September 2, 2026, is subject to court approval and customary closing conditions, as it is being conducted through an assignment for the benefit of creditors (ABC) proceeding.

The strategic rationale behind this acquisition is to diversify cbdMD's revenue streams and reduce its reliance on the hemp category, which has faced increasing regulatory scrutiny. By incorporating Twinlab and its associated brands—Reserveage, Metabolife, and Alvita Tea—cbdMD aims to strengthen its position in the broader consumer wellness market. The combined unaudited trailing twelve months of revenue for both companies is projected to total around $30 million, which represents a significant increase compared to cbdMD's standalone revenue for the same period.

Founded in 1968, Twinlab has built a strong reputation for quality and innovation in the nutritional supplements and sports nutrition sectors. The company serves approximately 50,000 retail outlets, including major chains like Vitamin Shoppe and GNC, and has a robust presence on platforms like Amazon. This extensive distribution network, along with the brand equity of Twinlab, is expected to complement cbdMD's existing operations and enhance its market reach. The acquisition not only adds iconic brands to cbdMD's portfolio but also provides a stable home for Twinlab's legacy obligations, ensuring continuity for customers and partners.

The transaction aligns with cbdMD's ongoing strategy to evolve into a multi-brand consumer wellness platform. By integrating Twinlab's offerings, cbdMD will expand its reach into various consumer need states, including daily wellness, active lifestyle, weight management, and beauty. The acquisition follows cbdMD's earlier purchase of Bluebird Botanicals and reflects its commitment to building a diverse portfolio of trusted wellness brands that leverage shared infrastructure and operational efficiencies.

In the broader market context, this acquisition underscores the increasing consolidation within the consumer wellness sector as companies seek to diversify their product offerings and enhance their competitive positioning. As cbdMD integrates Twinlab's brands, it is likely to attract a wider consumer base and mitigate risks associated with the volatile hemp market. This strategic move may also signal a trend of established companies in the wellness space looking to acquire legacy brands with strong consumer recognition, thereby reinforcing their market presence and driving future growth.